loadpatents
name:-0.030088901519775
name:-0.026864051818848
name:-0.00059413909912109
Klein; J. Peter Patent Filings

Klein; J. Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Klein; J. Peter.The latest application filed is for "lpaat-beta inhibitors and uses thereof".

Company Profile
0.35.33
  • Klein; J. Peter - Vashon WA
  • Klein; J. Peter - Vashon Island WA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Lpaat-beta Inhibitors And Uses Thereof
App 20100189726 - BONHAM; Lynn ;   et al.
2010-07-29
Aryl triazines as LPAAT-.beta. inhibitors and uses thereof
Grant 7,618,968 - Bhatt , et al. November 17, 2
2009-11-17
LPAAT-.beta. inhibitors and uses thereof
Grant 7,608,620 - Bonham , et al. October 27, 2
2009-10-27
Pyrimidines And Uses Thereof
App 20090099183 - BHATT; Rama ;   et al.
2009-04-16
Pyrimidines and uses thereof
Grant 7,419,984 - Bhatt , et al. September 2, 2
2008-09-02
Manufacture of polyglutamate-therapeutic agent conjugates
Grant 7,399,860 - Kumar , et al. July 15, 2
2008-07-15
Aryl triazines as LPAAT-beta inhibitors and uses thereof
App 20080064700 - Bhatt; Rama ;   et al.
2008-03-13
Aryl triazines as LPAAT-.beta. inhibitors and uses thereof
Grant 7,291,616 - Bhatt , et al. November 6, 2
2007-11-06
Pyridines and uses thereof
App 20070178134 - Hong; Feng ;   et al.
2007-08-02
Uses of tricyclic compounds
Grant 7,247,630 - Gong , et al. July 24, 2
2007-07-24
Pyridines and uses thereof
Grant 7,208,507 - Hong , et al. April 24, 2
2007-04-24
LPAAT-.beta. inhibitors and uses thereof
Grant 7,199,238 - Bonham , et al. April 3, 2
2007-04-03
LPAAT-beta inhibitors and uses thereof
App 20070072856 - Gong; Baoqing ;   et al.
2007-03-29
Polyglutamic acid-camptothecin conjugates and methods of preparation
Grant 7,173,041 - Bhatt , et al. February 6, 2
2007-02-06
Polyglutamic acid-camptothecin conjugates and methods of preparation
Grant 7,153,864 - Bhatt , et al. December 26, 2
2006-12-26
Compounds having selective hydrolytic potentials
App 20060211713 - Porubek; David ;   et al.
2006-09-21
LPAAT-.beta. inhibitors and uses thereof
Grant 7,064,125 - Gong , et al. June 20, 2
2006-06-20
Compounds having selective hydrolytic potentials
Grant 7,053,096 - Porubek , et al. May 30, 2
2006-05-30
LPAAT-beta inhibitors and uses thereof
App 20060035896 - Bonham; Lynn ;   et al.
2006-02-16
Pyridines and uses thereof
App 20050182102 - Hong, Feng ;   et al.
2005-08-18
Therapeutic compounds for inhibiting interleukin-12 signals and method for using same
Grant 6,878,715 - Klein , et al. April 12, 2
2005-04-12
Pyridines and uses thereof
Grant 6,875,781 - Hong , et al. April 5, 2
2005-04-05
Pyridopyrimidine compounds and their uses
App 20050059685 - McKennon, Marc J. ;   et al.
2005-03-17
Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same
App 20050049262 - Klein, J. Peter ;   et al.
2005-03-03
Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same
App 20050032748 - Klein, J. Peter ;   et al.
2005-02-10
Pyridopyrimidine compounds and their uses
Grant 6,825,180 - McKennon , et al. November 30, 2
2004-11-30
Compounds having selective hydrolytic potentials
App 20040229836 - Porubek, David ;   et al.
2004-11-18
Pyrimidines and uses thereof
App 20040204386 - Bhatt, Rama ;   et al.
2004-10-14
Pyridines and uses thereof
App 20040198728 - Hong, Feng ;   et al.
2004-10-07
Compounds having selective hydrolytic potentials
Grant 6,780,865 - Porubek , et al. August 24, 2
2004-08-24
LPAAT-beta inhibitors and uses thereof
App 20040162288 - Gong, Baoqing ;   et al.
2004-08-19
Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same
Grant 6,774,130 - Klein , et al. August 10, 2
2004-08-10
Hydroxyl-containing compounds
Grant 6,693,105 - Underiner , et al. February 17, 2
2004-02-17
Pyridopyrimidine compounds and their uses
App 20040023995 - McKennon, Marc J. ;   et al.
2004-02-05
Phospholipase D inhibitors and uses thereof
App 20040002526 - Klein, J. Peter ;   et al.
2004-01-01
Manufacture of polyglutamate-therapeutic agent conjugates
App 20030224971 - Kumar, Anil M. ;   et al.
2003-12-04
Polyglutamic acid-camptothecin conjugates and methods of preparation
App 20030216289 - Bhatt, Rama ;   et al.
2003-11-20
Polyglutamic acid-camptothecin conjugates and methods of preparation
App 20030211973 - Bhatt, Rama ;   et al.
2003-11-13
Hydroxyl-containing compounds
App 20030207901 - Underiner, Gail E. ;   et al.
2003-11-06
Tricyclic compounds and their uses
App 20030162801 - Gong, Baoqing ;   et al.
2003-08-28
Aryl triazines as LPAAT-SS inhibitors and uses thereof
App 20030153570 - Bhatt, Rama ;   et al.
2003-08-14
LPAAT-beta inhibitors and uses thereof
App 20030100557 - Finney, Robert ;   et al.
2003-05-29
Manufacture of polyglutamate-therapeutic agent conjugates
App 20030054977 - Kumar, Anil ;   et al.
2003-03-20
Polyglutamic acid-camptothecin conjugates and methods of preparation
App 20020183243 - Bhatt, Rama ;   et al.
2002-12-05
Benzoxazole LPAAT-B inhibitors and uses thereof
App 20020107269 - Bonham, Lynn ;   et al.
2002-08-08
Tricyclic Fused Xanthine Compounds And Their Uses
App 20020103211 - Gong, Baoqing ;   et al.
2002-08-01
LPAAT-B inhibitors and uses thereof
App 20020103195 - Bonham, Lynn ;   et al.
2002-08-01
Polyglutamic acid-camptothecin conjugates and methods of preparation
App 20020077290 - Bhatt, Rama ;   et al.
2002-06-20
Manufacture of polyglutamate-therapeutic agent conjugates
App 20020077279 - Kumar, Anil M. ;   et al.
2002-06-20
Therapeutic Compounds For Inhibiting Interleukin-12 Signaling And Methods For Using Same
App 20020028823 - KLEIN, J. PETER ;   et al.
2002-03-07
Polyglutamic acid-camptothecin conjugates and methods of preparation
App 20020016285 - Bhatt, Rama ;   et al.
2002-02-07
Electronegative-substituted long chain xanthine compounds
Grant 6,020,337 - Leigh , et al. February 1, 2
2000-02-01
Epoxide-containing compounds
Grant 5,866,576 - Underiner , et al. February 2, 1
1999-02-02
Amino-alcohol substituted cyclic compounds
Grant 5,837,703 - Kumar , et al. November 17, 1
1998-11-17
Substituted amino alkyl compounds
Grant 5,817,662 - Klein , et al. October 6, 1
1998-10-06
Amine substituted xanthinyl compounds
Grant 5,807,861 - Klein , et al. September 15, 1
1998-09-15
Therapeutic compounds containing pyrimidinyl moieties
Grant 5,807,862 - Klein , et al. September 15, 1
1998-09-15
Amine substituted compounds
Grant 5,801,182 - Klein , et al. September 1, 1
1998-09-01
Amino alcohol substituted cyclic compounds
Grant 5,801,181 - Michnick , et al. September 1, 1
1998-09-01
Hydroxyl-containing xanthine compounds
Grant 5,780,476 - Underiner , et al. July 14, 1
1998-07-14
Oxime substituted therapeutic compounds
Grant 5,770,595 - Klein , et al. June 23, 1
1998-06-23
Method for treating symptoms of a neurodegenerative condition
Grant 5,756,511 - West , et al. May 26, 1
1998-05-26
Substituted amino alcohol compounds
Grant 5,641,783 - Klein , et al. June 24, 1
1997-06-24
Asymmetric synthesis of chiral secondary alcohols
Grant 5,629,423 - Klein , et al. May 13, 1
1997-05-13
Substituted long chain alcohol xanthine compounds
Grant 5,473,070 - Underiner , et al. December 5, 1
1995-12-05
Cell signaling inhibitors
Grant 5,470,878 - Michnick , et al. November 28, 1
1995-11-28
Olefin-substituted long chain xanthine compounds
Grant 5,354,756 - Underiner , et al. October 11, 1
1994-10-11
Substituted aminoalkyl xanthine compounds
Grant 5,340,813 - Klein , et al. August 23, 1
1994-08-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed